As of 2025-03-20, the Relative Valuation of Alliance Pharma PLC (APH.L) is (87.13) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 64.20 GBP, the upside of Alliance Pharma PLC based on Relative Valuation is -235.7%.
The range of the Relative Valuation is (73.93) - (101.26) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 17.4x | 13.4x |
| Forward P/E multiples | 11.9x - 16.3x | 14.6x |
| Fair Price | (73.93) - (101.26) | (87.13) |
| Upside | -215.2% - -257.7% | -235.7% |
| Date | P/E |
| 2025-03-13 | -10.31 |
| 2025-03-12 | -10.30 |
| 2025-03-11 | -10.29 |
| 2025-03-10 | -10.30 |
| 2025-03-07 | -10.06 |
| 2025-03-06 | -10.06 |
| 2025-03-05 | -10.08 |
| 2025-03-04 | -9.98 |
| 2025-03-03 | -9.98 |
| 2025-02-28 | -10.01 |
| 2025-02-27 | -10.06 |
| 2025-02-26 | -9.95 |
| 2025-02-25 | -9.75 |
| 2025-02-24 | -9.75 |
| 2025-02-21 | -9.79 |
| 2025-02-20 | -9.75 |
| 2025-02-19 | -9.72 |
| 2025-02-18 | -9.85 |
| 2025-02-17 | -9.87 |
| 2025-02-14 | -9.90 |
| 2025-02-13 | -9.90 |
| 2025-02-12 | -9.90 |
| 2025-02-11 | -9.90 |
| 2025-02-10 | -9.88 |
| 2025-02-07 | -9.90 |
| 2025-02-06 | -9.88 |
| 2025-02-05 | -9.85 |
| 2025-02-04 | -9.85 |
| 2025-02-03 | -9.85 |
| 2025-01-31 | -9.87 |
| 2025-01-30 | -9.85 |
| 2025-01-29 | -9.84 |
| 2025-01-28 | -9.84 |
| 2025-01-27 | -9.85 |
| 2025-01-24 | -9.85 |
| 2025-01-23 | -9.84 |
| 2025-01-22 | -9.85 |
| 2025-01-21 | -9.84 |
| 2025-01-20 | -9.82 |
| 2025-01-17 | -9.82 |
| 2025-01-16 | -9.84 |
| 2025-01-15 | -9.85 |
| 2025-01-14 | -9.84 |
| 2025-01-13 | -9.85 |
| 2025-01-10 | -9.84 |
| 2025-01-09 | -7.14 |
| 2025-01-08 | -7.08 |
| 2025-01-07 | -7.40 |
| 2025-01-06 | -7.39 |
| 2025-01-03 | -7.37 |